Express Pharma August 2024
India's Foremost Pharma & Biotech Magazine ~ Forging The Path For Tomorrow's Therapeutics
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide:…
With promising Phase IIa results and a dual GLP-1/GIP receptor mechanism, VK2735 could soon compete directly with tirzepatide in…
FOPE organises workshop on human error reduction at Hyderabad
Regulatory officials as well as industry leaders and experts came together to discuss strategies for minimising errors and…
Lupin secures tentative U.S. FDA approval for generic HIV treatment under PEPFAR
Lupin to manufacture and supply affordable Emtricitabine and Tenofovir Alafenamide tablets from Nagpur facility to low and…
Vector Consulting Group reveals strategies for pharma firms to boost agility and cost efficiency in…
Strategies to increase output by 40-70% in Operations and R&D; Reduce of lab incidents by 50-70%
Zydus receives approval from COFEPRIS of Mexico to market Mamitra
The Mexican regulatory authority has granted marketing approval for a Trastuzumab biosimilar to treat various cancers
NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013
Action is taken against companies found selling formulations at prices higher than the permissible price
Government schemes bolster startup growth in India’s pharmaceutical sector
Government of India’s new schemes aim to enhance innovation and investment in pharmaceutical startups, with a focus on research,…
Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India:…
GlobalData reports the rise in HER2+ breast cancer cases, stressing the importance of cost-effective biosimilars as Zydus and…
Dual-action therapy shows promise against aggressive oral cancer
A new treatment combining tiny iron particles and nitric oxide gas shows promise in targeting oral cancer cells for destruction